By share count, mtnb is my largest holding. I have not seen any mention of lymph system work or amrn. Fungal infections, cancer, inflammation is mentioned on their latest slide deck. They could partner with amrn, since it is a delivery system. But no mention of amrn to this point.
Still waiting for mtnb to announce a funding solution for a p3 fungal study, and to continue operations into next year. So perhaps amrn is the long awaited partner announcement. But i think it is a longshot.
News 
Market Data 
Discover 
